Document Detail

Effects of hydralazine on the pulmonary vasculature and respiratory control in humans.
MedLine Citation:
PMID:  17911356     Owner:  NLM     Status:  MEDLINE    
This study sought: (1) to clarify the effects of hydralazine on both the pulmonary vasculature and respiratory control in euoxia and hypoxia in healthy humans; and (2) to determine whether hydralazine alters the expression of genes regulated by hypoxia-inducible factor 1 (HIF-1). Ten volunteers participated in two 2 day protocols. Hydralazine (25 mg) or placebo was administered at 1 pm and 11 pm on the first day, and at 1 pm on the second day. In the mornings and afternoons of both days, we measured plasma vascular endothelial growth factor (VEGF) and erythropoietin (EPO) concentrations (both HIF-1-regulated gene products), systemic arterial blood pressure, and changes in heart rate, cardiac output, maximal systolic pressure difference across the tricuspid valve (delta Pmax) and ventilation in response to 20 min of isocapnic hypoxia. Recent hydralazine: (1) decreased diastolic blood pressure; (2) increased heart rate and cardiac output in euoxia and hypoxia whilst having no effect on delta Pmax; and (3) increased the ventilatory sensitivity to hypoxia. Hydralazine had no effect on plasma EPO or VEGF concentration. We conclude that hydralazine increases the sensitivity of the ventilatory response to hypoxia, but lacks any effect on the pulmonary vasculature at the dose studied. It did not affect the expression of HIF-1-regulated genes.
Chun Liu; George M Balanos; Marzieh Fatemian; Thomas G Smith; Keith L Dorrington; Peter A Robbins
Related Documents :
24020096 - Poincare plot of heart rate variability: an approach towards explaining the cardiovascu...
2022566 - Attenuated carotid body hypoxic sensitivity after prolonged hypoxic exposure.
24206006 - Relationship of body compositional and nutritional parameters with blood pressure in ad...
24848636 - The relationship between bmi and blood pressure in children aged 7-12 years in ankara, ...
3661966 - Physical characteristics and clinical evaluation of a new disposable fibreoptic transdu...
2555106 - Endogenous digoxin-like immunoreactive factor and digitalis-like factor associated with...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2007-10-02
Journal Detail:
Title:  Experimental physiology     Volume:  93     ISSN:  0958-0670     ISO Abbreviation:  Exp. Physiol.     Publication Date:  2008 Jan 
Date Detail:
Created Date:  2007-12-31     Completed Date:  2008-03-28     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9002940     Medline TA:  Exp Physiol     Country:  England    
Other Details:
Languages:  eng     Pagination:  104-14     Citation Subset:  IM    
Department of Physiology, Anatomy and Genetics, University of Oxford, Sherrington Building, Parks Road, Oxford OX1 3PT, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Blood Pressure / drug effects
Cardiac Output / drug effects
Erythropoietin / biosynthesis,  genetics
Gene Expression / drug effects
Heart Rate / drug effects
Hydralazine / pharmacology*
Hypoxia-Inducible Factor 1 / genetics,  physiology
Pulmonary Circulation / drug effects*
Respiratory Mechanics / drug effects*
Vascular Endothelial Growth Factor A / biosynthesis,  genetics
Vasodilator Agents / pharmacology*
Grant Support
//Wellcome Trust
Reg. No./Substance:
0/Hypoxia-Inducible Factor 1; 0/Vascular Endothelial Growth Factor A; 0/Vasodilator Agents; 11096-26-7/Erythropoietin; 86-54-4/Hydralazine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Resistance training in men is associated with increased arterial stiffness and blood pressure but do...
Next Document:  Experimental hyperthyroidism increases expression of parathyroid hormone-related peptide and type-1 ...